<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00958399</url>
  </required_header>
  <id_info>
    <org_study_id>0701M00264</org_study_id>
    <nct_id>NCT00958399</nct_id>
  </id_info>
  <brief_title>Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers</brief_title>
  <official_title>Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tate and Lyle Ingredients France</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Research suggests dietary fiber may play a role in weight management, and fiber consumption&#xD;
      is inversely associated with body weight, body fat, and BMI in cross-sectional studies. These&#xD;
      effects may be mediated by increased satiety, reduced food intake, or changes in blood levels&#xD;
      of glucose, insulin, and gut hormones.&#xD;
&#xD;
      The purpose of this study is to determine the satiety, glycemic, hormonal, and&#xD;
      gastrointestinal responses of novel fiber supplements.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Satiety</measure>
    <time_frame>0, 15, 30, 45, 60, 90, 120, 180, 215 minutes postprandially</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ad libitum food intake</measure>
    <time_frame>180 minutes postprandially and over 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ghrelin, polypeptide YY (PYY), and glucagon-like peptide-1 (GLP-1) response</measure>
    <time_frame>0, 30, 60 minutes postprandially</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal tolerance and fecal chemistry</measure>
    <time_frame>following 7 days of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose/Insulin Response</measure>
    <time_frame>0, 15, 30, 45, 60, 90, 120, 180 minutes postprandially</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>No fiber</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No fiber added to study products</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistant Starch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Muffins, cereal, and bars made with a resistant starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Resistant starch + soluble fiber</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Muffins, cereal, and bars made with a mixture of resistant starch and a soluble fiber</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fiber made from corn starch</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Muffins, cereal, and bars made with novel corn fiber</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fiber made from corn starch + soluble fiber</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Muffins, cereal, and bars made with a mixture of novel corn fiber and a soluble fiber</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Low fiber muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)</description>
    <arm_group_label>No fiber</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Resistant Starch</intervention_name>
    <description>25 g resistant starch, administered in a muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)</description>
    <arm_group_label>Resistant Starch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Resistant starch + soluble fiber</intervention_name>
    <description>25 g fiber as resistant starch and a soluble fiber, administered in a muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)</description>
    <arm_group_label>Resistant starch + soluble fiber</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fiber made from corn starch</intervention_name>
    <description>25 g fiber made from corn starch, administered in a muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)</description>
    <arm_group_label>Fiber made from corn starch</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fiber made from corn starch + soluble fiber</intervention_name>
    <description>25 g fiber as a fiber made from corn starch and a soluble fiber, administered in a muffin, hot cereal and beverage (acute phase) or fiber bars and beverage (chronic phase)</description>
    <arm_group_label>Fiber made from corn starch + soluble fiber</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy men and women&#xD;
&#xD;
          -  age 18-60 years&#xD;
&#xD;
          -  non-smoking&#xD;
&#xD;
          -  not taking medication&#xD;
&#xD;
          -  non-dieting (weight stable in prior 3 months)&#xD;
&#xD;
          -  BMI 18-27&#xD;
&#xD;
          -  English literacy&#xD;
&#xD;
          -  ability to give blood&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  do not regularly consume breakfast&#xD;
&#xD;
          -  food allergies to ingredients found in study products&#xD;
&#xD;
          -  dislike for muffins, fiber bars, or hot cereal&#xD;
&#xD;
          -  BMI &lt;18 or &gt;27&#xD;
&#xD;
          -  diagnosed cardiovascular, renal, or hepatic disease&#xD;
&#xD;
          -  diabetes mellitus (fasting blood sugar &gt;126 mg/dl)&#xD;
&#xD;
          -  cancer in previous 5 years (except basal cell carcinoma of the skin)&#xD;
&#xD;
          -  any gastrointestinal disease or condition&#xD;
&#xD;
          -  recent bacterial infection (&lt; 3 months)&#xD;
&#xD;
          -  recent or concurrent participation in an intervention research study&#xD;
&#xD;
          -  history of drug or alcohol abuse in prior 6 months&#xD;
&#xD;
          -  use of lipid-lowering, anti-hypertensive, or anti-inflammatory steroid medication&#xD;
&#xD;
          -  restrained eaters&#xD;
&#xD;
          -  vegetarians&#xD;
&#xD;
          -  people who eat more than approximately 15 grams of fiber per day&#xD;
&#xD;
          -  women who are pregnant or lactating&#xD;
&#xD;
          -  women with irregular menstrual cycles&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joanne L Slavin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota - General Clinical Research Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <study_first_submitted>August 12, 2009</study_first_submitted>
  <study_first_submitted_qc>August 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2009</study_first_posted>
  <last_update_submitted>February 3, 2012</last_update_submitted>
  <last_update_submitted_qc>February 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>satiety</keyword>
  <keyword>fiber</keyword>
  <keyword>food intake</keyword>
  <keyword>gut hormones</keyword>
  <keyword>visual analog scales</keyword>
  <keyword>microflora</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

